The "Longevity Bro" Problem: Why More Biomarkers Doesn't Mean a Longer Life

We built Astrea the way a lot of small software studios build their second product: opportunistically. After our first health-related app, Vitalina, found some early traction letting people export and actually own their Apple Health data, we saw how many of those exports were being pulled for one reason: people trying to understand their own training and recovery. Martin, Astrea’s co-founder, and I are both genuinely into fitness and health ourselves, so putting more time into that space wasn’t a hard call.

What surprised me was what happened when I started reading everything I could find on longevity. I went deep into the research, the podcasts, the protocols, and the first thing that struck me was a vibe. The scene is overwhelmingly male, and pretty elitist with it. The moment that really stuck was seeing people casually refer to their “health stack.” I spent my whole career around “tech stacks”: the specific set of tools, frameworks, and services a team assembles to build and run a piece of software, usually compared and ranked against other teams’ choices. Hearing the same word applied to a body instantly told me how this world thinks about one: as a system to be assembled, benchmarked, and optimized against everyone else’s system. It read less like health advice and more like a leaderboard. That’s the opposite of what we want Astrea to be, and it’s worth explaining why.

Quick digest

• “Longevity bro” describes a data-heavy, self-experimentation culture that treats aging like an engineering problem: more biomarkers and protocols don’t automatically buy more healthy years.
• Even the most closely monitored person in the space is a useful example: Bryan Johnson reportedly spends around $2 million a year on his Blueprint protocol (Pringle, 2024), yet was still diagnosed in 2026 with autoimmune gastritis, a condition that had gone undetected despite years of testing (Mammoser, 2026).
• Many popular biohacks (extended fasting, cold exposure, aggressive ketogenic diets) were developed and tested on samples that skewed heavily male, sometimes literally male mice (Beery & Zucker, 2011).
• Women live longer than men on average but spend more of those extra years in poorer health: a global “healthspan gap” of 12.1 years for women versus 9.3 for men (GBD 2023 Health Effects Collaborators, 2026).
• The scene’s real entry cost is money and free time, which quietly reinforces who already had the most of both; single-parent households, who face documented time poverty, are disproportionately headed by women (U.S. Census Bureau, 2024; Yang, 2025).
• A research- and clinically-grounded counter-movement, led largely by women, is reframing longevity around hormonal health, muscle mass, and bone density instead of stacking more supplements and tests.

What “Longevity Bro” Actually Means

“Longevity bro” isn’t really about any one person. It’s shorthand for a specific approach: track everything, intervene aggressively, and treat your own results as proof. It’s evidence-light in a very particular way. The tracking is real and often rigorous. What’s missing is the step where an N=1 self-experiment gets tested against a control group before it’s presented as a protocol everyone should follow.

Bryan Johnson is the clearest public example, and it’s worth sticking to what’s documented rather than speculating about him personally. He has reported spending roughly $2 million a year on his Blueprint protocol: over 100 daily supplements, a team of physicians, and a long list of experimental interventions aimed at reversing his biological age (Pringle, 2024). In July 2026, he announced a diagnosis of autoimmune gastritis, a chronic condition where the immune system attacks the stomach lining. It had gone undetected for years, showing up only as persistently low iron, until his medical team pursued an endoscopy and biopsies (Mammoser, 2026). Gastroenterologists who commented on the diagnosis noted the condition is genuinely difficult to catch even under thorough medical care, because it’s often silent (Mammoser, 2026).

This isn’t a “gotcha” aimed at him personally. It’s a useful illustration: enormous monitoring, expert support, and money didn’t guarantee the thing they were supposedly optimizing for. More data points don’t automatically add up to a longer, healthier life. What predicts healthy aging is closer to the unglamorous basics: resistance training, adequate sleep, cardiovascular fitness, and consistency over decades. None of that requires a six-figure “stack.”

Why the Scene Skews Male

The public face of longevity is a specific demographic (Bryan Johnson, Peter Attia, David Sinclair, Andrew Huberman), and that’s not just a perception problem. A few forces reinforce it.

The culture largely grew out of Silicon Valley’s “quantified self” movement, where aging gets framed as a bug to patch rather than a process to support: the same optimize-and-ship mindset a lot of tech-industry men already apply to software.

There’s also a capital and risk-tolerance dynamic. Extreme, expensive self-experimentation like unproven stem cell therapies abroad, aggressive supplement regimens, or extensive private testing requires disposable income and a willingness to take on personal risk in public. And the media mechanics favor spectacle: a founder swapping blood plasma or swallowing 100 pills a day makes a far easier headline than a well-run, unglamorous prevention study.

None of this means the individual men in the space act in bad faith. Actually, several, like Attia and Sinclair, do serious, credentialed work. It means the incentives of the scene as a whole reward drama over evidence, and that skew has a real downstream cost.

There’s also a cost dimension underneath the gender skew that’s worth naming on its own. Even a modest version of a longevity protocol takes real money and, more than that, real time: hours for training, meal prep, sleep, and recovery routines, plus the flexibility to protect all of it. That combination is hardest to come by for the people already stretched thinnest. In the US, family households with no spouse present are far more likely to be headed by a woman than a man (15 million versus 6 million in the most recent Census Bureau estimates), and research on caregiving finds that time poverty, having too little discretionary time left after work and care duties, is a measurable burden with real downstream effects (U.S. Census Bureau, 2024; Yang, 2025). A culture built around $2 million-a-year protocols doesn’t just skew male: it quietly reinforces who already had the time and money to spare, while the people who could benefit most from better information about their own bodies are often the least able to access it.

Why That’s a Real Problem, Not Just a Vibe

The male skew isn’t only a representation issue: it shows up in the underlying evidence base. Research bias here is well documented and predates the current biohacking trend by decades. A landmark 2011 analysis found male-only studies outnumbered female-only studies roughly 5.5 to 1 across eight of ten biomedical research fields, driven partly by the outdated assumption that female hormonal cycles simply add unwanted variability to a study (Beery & Zucker, 2011). In sports and exercise medicine specifically, a review of three major journals found that only 39% of more than six million research participants were women (Costello et al., 2014).

That gap matters for the exact protocols the longevity scene popularizes. Extended fasting is a good example: a 2022 review of human trials found intermittent fasting affects reproductive hormones differently by sex, lowering sex hormone–binding globulin and androgen markers in women and reducing testosterone in men, with effects on the hypothalamic-pituitary-ovarian axis that don’t have a male equivalent (Cienfuegos et al., 2022). Cold exposure carries a similar asymmetry: a woman’s core body temperature rises roughly 0.3–0.7°C in the luteal phase due to progesterone’s thermogenic effect, changing how the body handles heat and cold stress across the month in ways most cold-exposure protocols don’t account for (Baker et al., 2020). None of this means fasting or cold plunges are bad; it means a protocol validated mostly on men doesn’t transfer 1:1, and thyroid and cycle regulation are exactly where that gap tends to show up first.

Zoom out, and there’s a bigger asymmetry: women live longer than men on average but spend more of those extra years in poor health. A 2026 Global Burden of Disease analysis covering more than three decades of data found the average global “morbidity gap” (years lived with disease or disability) was 12.1 years for women versus 9.3 for men, and that gap has been widening, not closing (GBD 2023 Health Effects Collaborators, 2026). A longevity culture built mostly on male self-experimentation is, by definition, not optimized to close it.

The Evidence-Based Counter-Movement

While the loudest voices in longevity are still mostly men, a substantial, credentialed counter-movement has been building. Much of it is led by women who research or treat female physiology directly.

Exercise physiologist Dr. Stacy Sims has spent her career arguing that “women are not small men,” focusing on how thermoregulation, hydration, and fueling needs shift across the menstrual cycle, the subject of her book ROAR (Sims & Yeager, 2016). Dr. Mary Claire Haver, a board-certified OB-GYN and Menopause Society Certified Practitioner, translates the research on perimenopause and menopause (muscle mass, bone density, metabolic health) into practical guidance, most recently in The New Menopause (Haver, 2024). Dr. Rhonda Patrick, who holds a PhD in biomedical science and co-founded FoundMyFitness, is one of the most visible science communicators translating peer-reviewed aging research for a general audience. And in the lab, Dr. Vera Gorbunova, a professor of biology and co-director of the Rochester Aging Research Center, leads primary research into what makes species like the naked mole rat both exceptionally long-lived and cancer-resistant: the mechanistic science of aging, not the self-experimentation layered on top of it.

The throughline across all four is a shift in framing: instead of treating aging as a system to hack faster than everyone else, the focus moves to protecting the things that reliably predict a longer and better-functioning life: muscle mass, bone density, hormonal stability, cardiovascular fitness.

What This Means in Practice

You don’t need to distrust every biomarker or throw out data to avoid the “longevity bro” trap. The point isn’t less information: it’s better context around the information you already have.

• Ask what a protocol was tested on. If a fasting or training protocol doesn’t specify who it was studied in, assume it skews male until proven otherwise, and be more cautious applying it unmodified if you’re a woman, especially around your cycle or during perimenopause.
• Track your own trend, not someone else’s stack. A single expensive protocol validated on one very unusual, very wealthy man isn’t a benchmark for anyone else. Your own baseline (sleep, HRV, training load over time) tells you more than a “health stack” comparison ever will.
• Prioritize the boring basics first. Resistance training, sleep, and cardiovascular fitness have decades of broad-based evidence behind them. Layer anything experimental on top of that foundation, not instead of it.
• Treat sex-specific physiology as core information. Thyroid function, progesterone, and cycle phase aren’t edge cases to work around: they’re part of how a body actually runs.
• Ask who a protocol assumes has spare time and money. A routine that only works with a personal chef, a flexible schedule, or a five-figure testing budget describes a lifestyle a small group can buy into, not a health standard everyone else is failing to meet.

The bigger question this all points to isn’t how to build a better, still-expensive “stack.” It’s how to make longevity-supportive habits accessible to people who don’t have $2 million, a live-in medical team, or three free hours a day, not just to a different body type. That’s the same philosophy behind how we built Astrea, and part of why this “Connection & Longevity” pillar exists as its own space on our blog, separate from feature walkthroughs. You can read more about our approach on our About page. We priced Astrea as a single Founding Member purchase rather than a subscription (see why we chose a one-time payment over a subscription) partly because we didn’t want to build another “stack” people feel they have to keep buying into to stay in the game. Calm, evidence-based, and useful to more than one kind of body and one kind of budget: that’s the standard we’re holding ourselves to.

For more on how we think about longevity and connection, visit the Connection & Longevity hub.

FAQ

Is biohacking worth it at all, or should I ignore it entirely? Not all of it, and not none of it. Some biohacking-adjacent practices (resistance training, sleep consistency, cardiovascular work) have strong, broad evidence behind them and are worth prioritizing. Others (extreme fasting protocols, unproven supplement stacks, experimental therapies) have thinner evidence, especially for women, and are worth more scrutiny before you adopt them.

Does this mean fasting or cold exposure is bad for women? No. It means the research base is thinner and less sex-specific than the marketing around these practices suggests. Effects can differ by cycle phase and individual hormonal status, so what works well for one person may need adjusting for another, particularly around the luteal phase when progesterone is elevated (Baker et al., 2020).

Why does biohacking culture skew so male? A mix of factors: its roots in Silicon Valley’s “quantified self” culture, which frames aging as an engineering problem; the capital and risk tolerance needed for expensive, public self-experimentation; and media incentives that favor dramatic, spectacle-driven stories over slower, evidence-based prevention work.

Is more biomarker tracking always better? Not automatically. Tracking is useful when it’s tied to a clear question and interpreted against your own trend over time. Tracking for its own sake, or to compete with someone else’s “stack,” doesn’t reliably translate into better health outcomes, as the limits of even extremely well-monitored self-experimentation show.

What should I actually pay attention to if I care about healthy aging? The basics with the strongest evidence: resistance training to protect muscle and bone, consistent sleep, cardiovascular fitness, and, for women specifically, attention to hormonal shifts across the cycle, perimenopause, and menopause, since standard protocols weren’t built with those in mind.

Doesn’t taking longevity seriously require a lot of money and free time? The current culture around it often implies that, but the habits with the strongest evidence, resistance training, sleep, and cardiovascular fitness, don’t require a six-figure budget. What they do require is time, which is exactly the resource caregivers and single parents tend to have the least of (Yang, 2025). Small, consistent steps, a short strength session, an earlier bedtime, a regular walk, count for more than hours spent chasing a protocol you can’t sustain.

Sources

Baker, F. C., Siboza, F., & Fuller, A. (2020). Temperature regulation in women: Effects of the menstrual cycle. Temperature, 7(3), 226–262. https://doi.org/10.1080/23328940.2020.1735927

Beery, A. K., & Zucker, I. (2011). Sex bias in neuroscience and biomedical research. Neuroscience & Biobehavioral Reviews, 35(3), 565–572. https://doi.org/10.1016/j.neubiorev.2010.07.002

Cienfuegos, S., Corapi, S., Gabel, K., Ezpeleta, M., Kalam, F., Lin, S., & Pavlou, V. (2022). Effect of intermittent fasting on reproductive hormone levels in females and males: A review of human trials. Nutrients, 14(11), 2343. https://doi.org/10.3390/nu14112343

Costello, J. T., Bieuzen, F., & Bleakley, C. M. (2014). Where are all the female participants in Sports and Exercise Medicine research? European Journal of Sport Science, 14(8), 847–851. https://doi.org/10.1080/17461391.2014.911354

GBD 2023 Health Effects Collaborators. (2026). Global, regional, and national trends in the morbidity gap and contributing diseases, injuries, and risk factors, 1990–2023: A systematic analysis for the Global Burden of Disease Study 2023. The Lancet Public Health. https://doi.org/10.1016/S2468-2667(26)00098-8

Haver, M. C. (2024). The new menopause: Navigating your path through hormonal change with purpose, power, and facts. Rodale Books.

Mammoser, G. (2026, July 14). Longevity “guru” Bryan Johnson reveals autoimmune gastritis diagnosis. Healthline. https://www.healthline.com/health-news/longevity-guru-bryan-johnson-diagnosed-autoimmune-gastritis

Pringle, E. (2024, February 17). Exclusive: Bryan Johnson, the tech founder spending millions to be 18 again, says his goal is to make death optional. Fortune. https://fortune.com/well/2024/02/17/bryan-johnson-blueprint-protocol-aim-death-optional/

Sims, S. T., & Yeager, S. (2016). ROAR: How to match your food and fitness to your unique female physiology for optimum performance, great health, and a strong, lean body for life. Rodale Books.

U.S. Census Bureau. (2024, May 30). Census Bureau releases new estimates on families and living arrangements [Press release]. https://www.census.gov/newsroom/press-releases/2024/families-living-arrangements.html

Yang, S. (2025). Caregivers’ time poverty, parenting styles and children’s growth mindset. British Journal of Psychology, 116(4), 877–906. https://doi.org/10.1111/bjop.12797

A note from us We’re Martin and Marina, Astrea’s co-founders. We’re both into data and serious about our own training, but neither of us is a doctor or a clinical researcher. The health and physiology claims in this article come from published, peer-reviewed research, not our own expertise, which is why every article ends with a Sources list above. If a claim doesn’t trace back to a real source, we cut it before it gets published.